Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy
Objective To evaluate the safety, efficacy and possible complications of 16-core transrectal prostate biopsies using two doses of ciprofloxacin for prophylaxis of infectious complications. Materials and Methods Sixteen-core prostate biopsies were performed on a number of patients with different sign...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Urologia
2015-02-01
|
Series: | International Brazilian Journal of Urology |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382015000100046&lng=en&tlng=en |
_version_ | 1811283984061038592 |
---|---|
author | Renato Caretta Chambó Fábio Hissachi Tsuji Hamilton Akihissa Yamamoto Carlos Márcio Nóbrega de Jesus |
author_facet | Renato Caretta Chambó Fábio Hissachi Tsuji Hamilton Akihissa Yamamoto Carlos Márcio Nóbrega de Jesus |
author_sort | Renato Caretta Chambó |
collection | DOAJ |
description | Objective To evaluate the safety, efficacy and possible complications of 16-core transrectal prostate biopsies using two doses of ciprofloxacin for prophylaxis of infectious complications. Materials and Methods Sixteen-core prostate biopsies were performed on a number of patients with different signs of potential prostate cancer. Complications were assessed both during the procedure and one week later. After the procedure, urine samples were collected for culture. The rate of post-biopsy complications, hospital visits and hospitalizations were also analyzed. Ciprofloxacin (500 mg) was administered two hours before, and eight hours after the procedure. Results The overall rate of post-biopsy complications was 87.32%, being 5.4% of those considered major complications due to hemorrhage, or to urinary retention. Eight patients required hospital treatment post-biopsy. Fever occurred in just one patient (0.29%). There was no incidence of orchitis, epididymitis, prostatitis, septicemia, hospitalization, or death. The urine culture showed positive results in five patients (2.15%). Conclusion One-day prophylaxis with ciprofloxacin proved to be safe and effective in the prevention of infectious complications following 16-core prostate biopsies. |
first_indexed | 2024-04-13T02:21:49Z |
format | Article |
id | doaj.art-530494f045fc4738b0df5b8aea87ae72 |
institution | Directory Open Access Journal |
issn | 1677-6119 |
language | English |
last_indexed | 2024-04-13T02:21:49Z |
publishDate | 2015-02-01 |
publisher | Sociedade Brasileira de Urologia |
record_format | Article |
series | International Brazilian Journal of Urology |
spelling | doaj.art-530494f045fc4738b0df5b8aea87ae722022-12-22T03:06:55ZengSociedade Brasileira de UrologiaInternational Brazilian Journal of Urology1677-61192015-02-01411465610.1590/S1677-5538.IBJU.2015.01.08S1677-55382015000100046Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsyRenato Caretta ChambóFábio Hissachi TsujiHamilton Akihissa YamamotoCarlos Márcio Nóbrega de JesusObjective To evaluate the safety, efficacy and possible complications of 16-core transrectal prostate biopsies using two doses of ciprofloxacin for prophylaxis of infectious complications. Materials and Methods Sixteen-core prostate biopsies were performed on a number of patients with different signs of potential prostate cancer. Complications were assessed both during the procedure and one week later. After the procedure, urine samples were collected for culture. The rate of post-biopsy complications, hospital visits and hospitalizations were also analyzed. Ciprofloxacin (500 mg) was administered two hours before, and eight hours after the procedure. Results The overall rate of post-biopsy complications was 87.32%, being 5.4% of those considered major complications due to hemorrhage, or to urinary retention. Eight patients required hospital treatment post-biopsy. Fever occurred in just one patient (0.29%). There was no incidence of orchitis, epididymitis, prostatitis, septicemia, hospitalization, or death. The urine culture showed positive results in five patients (2.15%). Conclusion One-day prophylaxis with ciprofloxacin proved to be safe and effective in the prevention of infectious complications following 16-core prostate biopsies.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382015000100046&lng=en&tlng=enprostateprostatic neoplasmsbiopsycomplications |
spellingShingle | Renato Caretta Chambó Fábio Hissachi Tsuji Hamilton Akihissa Yamamoto Carlos Márcio Nóbrega de Jesus Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy International Brazilian Journal of Urology prostate prostatic neoplasms biopsy complications |
title | Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy |
title_full | Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy |
title_fullStr | Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy |
title_full_unstemmed | Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy |
title_short | Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy |
title_sort | short term prophylaxis with ciprofloxacin in extended 16 core prostate biopsy |
topic | prostate prostatic neoplasms biopsy complications |
url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382015000100046&lng=en&tlng=en |
work_keys_str_mv | AT renatocarettachambo shorttermprophylaxiswithciprofloxacininextended16coreprostatebiopsy AT fabiohissachitsuji shorttermprophylaxiswithciprofloxacininextended16coreprostatebiopsy AT hamiltonakihissayamamoto shorttermprophylaxiswithciprofloxacininextended16coreprostatebiopsy AT carlosmarcionobregadejesus shorttermprophylaxiswithciprofloxacininextended16coreprostatebiopsy |